Why the study?
Do natriuretic peptides (BNP, NT-proBNP, NT-proANP) predict 1-year mortality in patients with chronic heart failure of presumed non-ischaemic origin?
Do natriuretic peptides (BNP, NT-proBNP, NT-proANP) predict 1-year mortality in patients with chronic heart failure of presumed non-ischaemic origin?
NT-proANP, NT-proBNP, and BNP are significant predictors of short-term mortality in non-ischemic chronic heart failure, with NT-proANP emerging as the strongest independent predictor.
No takes yet. Share an insight, caveat, or question.
NT-proANP may aid short-term risk stratification in non-ischaemic HF; leaves open comparative performance versus other peptides in prospective studies.
Stanton et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: